What’s Going On With Biogen Stock Tuesday?
Biogen Inc (NASDAQ: BIIB) shares are trading lower Tuesday. The company reported first-quarter results before the bell and the FDA approved its ALS therapy Tuesday afternoon.
Akebia Receives European Commission Approval For Vafseo For The Treatment Of Symptomatic Anaemia Associated With Chronic Kidney Disease In Adults On Chronic Maintenance Dialysis
Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced that the European Commission (EC) has granted marketing authorisation for Vafseo™ (vadadustat), an oral hypoxia-inducible factor prolyl
FDA Approves Treatment Of Amyotrophic Lateral Sclerosis Associated With A Mutation In The SOD1 Gene
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated
Virios Therapeutics Shares Almost Double In Trading Session – Here’s Why
Virios Therapeutics Inc (NASDAQ:VIRI) announced a program summary based on initial feedback from the FDA on its Phase 3 FM program…
Why Arbutus Biopharma Stock Is Plunging Today
The FDA has notified via verbal communication regarding a clinical hold on Arbutus Biopharma Corporation’s (NASDAQ:ABUS) AB-101 Investigational New Drug (IND) application. …
Abbott’s Life Support System Receives New FDA Clearances For CentriMag Blood Pump
Abbott (NYSE:ABT) today announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life support system. With the new indication, the CentriMag Blood
Artelo Biosciences Initiates The Phase 2a Portion Of Its CAReS Trial EvaluatingART27.13 For The Treatment Of Cancer-Related Anorexia And Weight Loss
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological
No Escape for Big Oil: US Supreme Court Denies Exxon, Chevron’s Climate-Change Case Venue Swap
The U.S. Supreme Court reportedly turned away five appeals by Exxon Mobil Corp (NYSE:XOM), Suncor Energy Inc (NYSE:SU), Chevron Corp (NYSE:CVX), and others to…
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023
Bluebird Bio Inc (NASDAQ:BLUE) has submitted its Biologics License Application (BLA) to the FDA seeking approval for lovotibeglogene autotemcel…
